Indantadol Hydrochloride

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameIndantadol Hydrochloride
Drug Alias NameIndantadol茚他多IndantadolumV-3381CCCNP-3381 +[11
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase inhibitorsGlutamate [NMDA] receptor antagonists
TargetsMonoamine oxidaseGlutamate [NMDA] receptor
Therapy Area/IndicationsPainDiabetic NeuropathiesCough
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[4
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChiesi Farmaceutici SPA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsPainDiabetic NeuropathiesCough

Other Information

ATC CodeN/A
Related LinksWikipedia